Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Yeda Research and Development
04.06.2019
A prestigious global ranking puts the Institute near the top for both citations and patents
29.04.2019
Biochemistry, Cancer, Personalized Medicine, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
The treatment, approved for use in 31 countries, is now being marketed in Germany, Italy, Israel and Mexico
19.03.2019
Two Korean concerns will invest 12 million dollars in companies based on Institute research
13.08.2018
WISe, the entrepreneurship club for Weizmann Institute of Science students, helped three alumni found a new company that could advance the edible...
09.08.2017
The Nature Index of Innovation 2017 points industry to institutions providing ideas behind inventions
17.05.2017
A lack of the protein citrin slows children's growth; blocking it in cancer slows tumor growth
23.02.2017
Dr. Bruce Lefker is currently working in the G-INCPM for one year as part of a five-year collaboration between the Weizmann Institute, Yeda...
13.06.2016
Biochemistry, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A new compound targets just one version of an ion pump, avoiding side effects
05.06.2016
Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Diagnostic Techniques and Drugs
The Weizmann Institute of Science in Rehovot, Israel, and Yeda Research...
16.03.2016
Portrazza is approved to by the US FDA to treat lung cancer
